Evidence map›Paper›PMID 24586281›Full record

ArticlePloS one2014

A descriptive model of patient readiness, motivators, and hepatitis C treatment uptake among Australian prisoners.

Lorraine Yap, Susan Carruthers, Sandra Thompson, Wendy Cheng, Jocelyn Jones, Paul Simpson, Alun Richards, Hla-Hla Thein, Paul Haber, Andrew Lloyd and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Opioid epidemic and liver disease.JHEP reports : innovation in hepatology · 2019
    Review
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Lorraine YapJustice Health Research Program, The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
Susan CarruthersNational Drug Research Institute, Curtin University, Perth, Western Australia, Australia.
Sandra ThompsonCombined Universities of Rural Health, Geraldton, Western Australia, Australia.
Wendy ChengRoyal Perth Hospital, Perth, Western Australia, Australia.
Jocelyn JonesNational Drug Research Institute, Curtin University, Perth, Western Australia, Australia.
Paul SimpsonJustice Health Research Program, The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
Alun RichardsOffender Health Services, Queensland Health, Queensland, Australia.
Hla-Hla TheinJustice Health Research Program, The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia ; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Paul HaberSydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
Andrew LloydInflammation and Infection Research Centre, University of New South Wales, Sydney, New South Wales, Australia.
Tony ButlerJustice Health Research Program, The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
UNSW Sydney · AUCurtin University · AUQueensland Health · AURoyal Perth Hospital · AUUniversity of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHepatitis C virus infection (HCV) has a significant global health burden with an estimated 2%-3% of the world's population infected, and more than 350,000 dying annually from HCV-related conditions including liver failure and liver cancer. Prisons potentially offer a relatively stable environment in which to commence treatment as they usually provide good access to health care providers, and are organised around routine and structure. Uptake of treatment of HCV, however, remains low in the community and in prisons. In this study, we explored factors affecting treatment uptake inside prisons and hypothesised that prisoners have unique issues influencing HCV treatment uptake as a consequence of their incarceration which are not experienced in other populations. METHOD AND

findingsWe undertook a qualitative study exploring prisoners' accounts of why they refused, deferred, delayed or discontinued HCV treatment in prison. Between 2010 and 2013, 116 Australian inmates were interviewed from prisons in New South Wales, Queensland, and Western Australia. Prisoners experienced many factors similar to those which influence treatment uptake of those living with HCV infection in the community. Incarceration, however, provides different circumstances of how these factors are experienced which need to be better understood if the number of prisoners receiving treatment is to be increased. We developed a descriptive model of patient readiness and motivators for HCV treatment inside prisons and discussed how we can improve treatment uptake among prisoners.

conclusionThis study identified a broad and unique range of challenges to treatment of HCV in prison. Some of these are likely to be diminished by improving treatment options and improved models of health care delivery. Other barriers relate to inmate understanding of their illness and stigmatisation by other inmates and custodial staff and generally appear less amenable to change although there is potential for peer-based education to address lack of knowledge and stigma.

Indexed as

Models, TheoreticalMotivationAdultAustraliaCross-Sectional StudiesFemaleHepatitis CHumansMaleMiddle AgedPrisonersQualitative ResearchRisk FactorsYoung Adult

Identifiers

PMID24586281
PMCPMC3937313
OpenAlexW1998667681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.